What You Need To Know
Jersey Shore earned The Joint Commission’s Gold Seal of Approval® for Center of Excellence for Pancreas, Liver, and Bile Duct Cancer Certification.
Jersey Shore is the only medical center to receive this certification on the East Coast and the second hospital to achieve this designation in the United States.
"This certification provides us with the framework to create a culture of excellence for those in our community. It's a huge accomplishment in recognition of our high-quality program and shows that patients with hepatobiliary cancers can receive the most advanced care right here in Monmouth and Ocean Counties."
Ronald Matteotti, M.D., medical director of the Hepatobiliary & Pancreatic Program and Chief of Hepatobiliary & Pancreatic Surgery at Jersey Shore University Medical Center
Left to Right: Jessica DiNapoli, MSPA, PA-C; Alexandria Shay, Surgical Coordinator; Ronald Matteotti, M.D., FACS, FMH, ABIHM, DABS, Medical Director, Hepatobiliary Surgery, Hackensack Meridian Health Cancer Care of Monmouth and Ocean counties and Chief, Hepatobiliary & Pancreatic Surgery, Jersey Shore University Medical Center; Jillian Cassidy, MSPA, PA-C; Dora Crowley, BSN, RN, Oncology Nurse Navigator
About Jersey Shore's Hepatobiliary Care Team
Jersey Shore’s integrated hepatobiliary care team offers:
- Rapid appointments to evaluate pancreatic masses
- Minimally invasive robotic surgery as well as complex open surgical procedures
- Advanced interventional endoscopic techniques to treat these cancers and their complications, such as blocked ducts that cause pain and impair quality of life
- Medical and radiation oncology treatments based on the latest research
- Clinical trial opportunities and other research initiatives designed to improve hepatobiliary cancer care
- Surveillance for patients at high risk of pancreatic cancer, with genetic counseling/testing and personalized screening
- Integrative health approaches and nurse navigators to ease patients’ experiences with cancer
About the Joint Commission’s Gold Seal of Approval®
Established in 2002 and awarded for a two-year period, The Joint Commission’s Disease-Specific Care Certification evaluates clinical programs across the continuum of care and addresses three core areas:
- Compliance with consensus-based national standards;
- Effective use of evidence-based clinical practice guidelines to manage and optimize care; and
- An organized approach to performance measurement and improvement activities.